Related Experiment Videos
Androgens and prostate cancer: are the descriptors valid?
Cancer Biology & Therapy
|August 2, 2005
Summary
The term "androgen-independent" cancer is inaccurate. Prostate cancers can grow without external androgens by remaining sensitive to low levels, suggesting "androgen depletion-independent" is a more precise description.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The term "androgen-independent" (AI) cancer is increasingly recognized as a misnomer in prostate cancer research.
- Prostate cancer progression is often linked to the androgen receptor (AR) signaling pathway.
Discussion:
- AR can be activated by low androgen concentrations, not just complete depletion.
- AR signaling can persist through protein modifications and interactions, even without external androgens.
- This suggests that prostate cancer does not necessarily bypass AR signaling to become "independent" of androgens.
Key Insights:
- "Androgen-independent" (AI) is an inaccurate term for advanced prostate cancer.
- Prostate cancer can maintain AR signaling sensitivity even with low androgen levels.
- The term "androgen depletion-independent" (ADI) more accurately reflects the underlying biology.
Outlook:
- Revising terminology may improve understanding of prostate cancer progression.
- Accurate terminology can guide the development of more effective therapeutic strategies.
- Further research into AR signaling mechanisms in ADI cancer is warranted.